Cargando…

The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy

BACKGROUND: Cystic echinococcosis (CE) is an important neglected zoonotic parasitic infection belonging to the subgroup of seven Neglected Zoonotic Disease (NZDs) included in the World Health Organization’s official list of 18 Neglected Tropical Diseases (NTDs). CE causes serious global human health...

Descripción completa

Detalles Bibliográficos
Autores principales: Piseddu, Toni, Brundu, Diego, Stegel, Giovanni, Loi, Federica, Rolesu, Sandro, Masu, Gabriella, Ledda, Salvatore, Masala, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546721/
https://www.ncbi.nlm.nih.gov/pubmed/28746395
http://dx.doi.org/10.1371/journal.pntd.0005771
_version_ 1783255601358307328
author Piseddu, Toni
Brundu, Diego
Stegel, Giovanni
Loi, Federica
Rolesu, Sandro
Masu, Gabriella
Ledda, Salvatore
Masala, Giovanna
author_facet Piseddu, Toni
Brundu, Diego
Stegel, Giovanni
Loi, Federica
Rolesu, Sandro
Masu, Gabriella
Ledda, Salvatore
Masala, Giovanna
author_sort Piseddu, Toni
collection PubMed
description BACKGROUND: Cystic echinococcosis (CE) is an important neglected zoonotic parasitic infection belonging to the subgroup of seven Neglected Zoonotic Disease (NZDs) included in the World Health Organization’s official list of 18 Neglected Tropical Diseases (NTDs). CE causes serious global human health concerns and leads to significant economic losses arising from the costs of medical treatment, morbidity, life impairments and fatality rates in human cases. Moreover, CE is endemic in several Italian Regions. The aim of this study is to perform a detailed analysis of the economic burden of hospitalization and treatment costs and to estimate the Disability Adjusted Life Years (DALYs) of CE in Italy. METHODS AND FINDINGS: In the period from 2001 to 2014, the direct costs of 21,050 Hospital Discharge Records (HDRs) belonging to 12,619 patients with at least one CE-related diagnosis codes were analyzed in order to quantify the economic burden of CE. CE cases average per annum are 901 (min—max = 480–1,583). Direct costs include expenses for hospitalizations, medical and surgical treatment incurred by public and private hospitals and were computed on an individual basis according to Italian Health Ministry legislation. Moreover, we estimated the DALYs for each patient. The Italian financial burden of CE is around € 53 million; the national average economic burden per annum is around € 4 million; the DALYs of the population from 2001 to 2014 are 223.35 annually and 5.26 DALYs per 10(5) inhabitants. CONCLUSION: In Italy, human CE is responsible for significant economic losses in the public health sector. In humans, costs associated with CE have been shown to have a great impact on affected individuals, their families and the community as a whole. This study could be used as a tool to prioritize and make decisions with regard to a surveillance system for this largely preventable yet neglected disease. It demonstrates the need of implementing a CE control program aimed at preventing the considerable economic and social losses it causes in high incidence areas.
format Online
Article
Text
id pubmed-5546721
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55467212017-08-12 The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy Piseddu, Toni Brundu, Diego Stegel, Giovanni Loi, Federica Rolesu, Sandro Masu, Gabriella Ledda, Salvatore Masala, Giovanna PLoS Negl Trop Dis Research Article BACKGROUND: Cystic echinococcosis (CE) is an important neglected zoonotic parasitic infection belonging to the subgroup of seven Neglected Zoonotic Disease (NZDs) included in the World Health Organization’s official list of 18 Neglected Tropical Diseases (NTDs). CE causes serious global human health concerns and leads to significant economic losses arising from the costs of medical treatment, morbidity, life impairments and fatality rates in human cases. Moreover, CE is endemic in several Italian Regions. The aim of this study is to perform a detailed analysis of the economic burden of hospitalization and treatment costs and to estimate the Disability Adjusted Life Years (DALYs) of CE in Italy. METHODS AND FINDINGS: In the period from 2001 to 2014, the direct costs of 21,050 Hospital Discharge Records (HDRs) belonging to 12,619 patients with at least one CE-related diagnosis codes were analyzed in order to quantify the economic burden of CE. CE cases average per annum are 901 (min—max = 480–1,583). Direct costs include expenses for hospitalizations, medical and surgical treatment incurred by public and private hospitals and were computed on an individual basis according to Italian Health Ministry legislation. Moreover, we estimated the DALYs for each patient. The Italian financial burden of CE is around € 53 million; the national average economic burden per annum is around € 4 million; the DALYs of the population from 2001 to 2014 are 223.35 annually and 5.26 DALYs per 10(5) inhabitants. CONCLUSION: In Italy, human CE is responsible for significant economic losses in the public health sector. In humans, costs associated with CE have been shown to have a great impact on affected individuals, their families and the community as a whole. This study could be used as a tool to prioritize and make decisions with regard to a surveillance system for this largely preventable yet neglected disease. It demonstrates the need of implementing a CE control program aimed at preventing the considerable economic and social losses it causes in high incidence areas. Public Library of Science 2017-07-26 /pmc/articles/PMC5546721/ /pubmed/28746395 http://dx.doi.org/10.1371/journal.pntd.0005771 Text en © 2017 Piseddu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Piseddu, Toni
Brundu, Diego
Stegel, Giovanni
Loi, Federica
Rolesu, Sandro
Masu, Gabriella
Ledda, Salvatore
Masala, Giovanna
The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title_full The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title_fullStr The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title_full_unstemmed The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title_short The disease burden of human cystic echinococcosis based on HDRs from 2001 to 2014 in Italy
title_sort disease burden of human cystic echinococcosis based on hdrs from 2001 to 2014 in italy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546721/
https://www.ncbi.nlm.nih.gov/pubmed/28746395
http://dx.doi.org/10.1371/journal.pntd.0005771
work_keys_str_mv AT piseddutoni thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT brundudiego thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT stegelgiovanni thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT loifederica thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT rolesusandro thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT masugabriella thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT leddasalvatore thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT masalagiovanna thediseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT piseddutoni diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT brundudiego diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT stegelgiovanni diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT loifederica diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT rolesusandro diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT masugabriella diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT leddasalvatore diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly
AT masalagiovanna diseaseburdenofhumancysticechinococcosisbasedonhdrsfrom2001to2014initaly